Immunologix Laboratories Expands Translational Sciences Team
News provided by
Share this article
Share this article
TAMPA, Fla., Feb. 16, 2021 /PRNewswire/ Immunologix Laboratories announces two additions to the Translational Sciences division with Corinna Fiorotti, Ph.D. as Executive Director, Translational Sciences and Safa Alvandkouhi as Director, Business Operations. The continued growth of Translational Sciences highlights Immunologix Laboratories commitment to building an unparalleled model of scientific partnership with our clients.
(PRNewsfoto/Immunologix Laboratories) We are excited about expanding our Translational Sciences team with the addition of Dr. Fiorotti as an Executive Director. Dr. Fiorotti brings extensive bioanalytical experience in both traditional and emergent therapeutic modalities, including monoclonal antibodies, bispecific and multi-domain therapeutics, antibody-drug conjugates and cell and gene therapies. Our clients are already benefiting from